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SUMMARY
Childhood varicella vaccination has not yet been introduced in the UK. To inform decision-
making about future vaccine programmes, data on the burden of varicella in general practice
over a 10-year period (01/01/2005–31/12/2014) was calculated by age and ethnicity, using
anonymised data from >8 million individuals in the Clinical Practice Research Datalink.
Varicella consultations peaked at 20 603 in 2007, then decreased annually in all age groups to 11
243 in 2014. Each year, consultation rates were common among infants, were highest among 1–3
year olds (61·2 consultations/1000 person-years in 2007, 39·7/1000 person-years in 2014) and then
fell with increasing age to <1·0/1000 person-years at ages 520 years. Varicella acquisition
appeared to be delayed in some ethnic groups, with lower consultation rates for children aged <3
years but increased rates for older children and adults aged 440 years among those of black
African, Afro-Caribbean, South Asian or other Asian ethnicity. Decreasing general practice
consultation rates over time could reﬂect changes in healthcare utilisation, with patients seeking
care in alternative settings such as Accident and Emergency Departments, although current data
prevent full assessment of this. Availability of data on varicella diagnoses across all health
settings would enable estimation of the total healthcare burden due to varicella and the cost-
effectiveness of introducing varicella vaccination.
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Varicella remains a common disease of childhood in
temperate countries such as the UK that do not
have universal childhood varicella vaccination pro-
grammes. In these countries, most individuals have
acquired varicella-zoster-virus infection by the age of
15 years [1]. In contrast, in some tropical climates,
the average age at infection is later, with an appre-
ciable proportion of the population remaining suscep-
tible in early adulthood [2]. Varicella is typically a
mild self-limiting disease in healthy children but com-
plications are more common in adulthood. Thus,
migrants from speciﬁc regions who move to temperate
countries after childhood can be at particular risk of
acquiring varicella as adults, with the risk of develop-
ing more severe disease.
In England, varicella vaccination is offered cur-
rently only to non-immune healthcare workers and
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to household contacts of immunosuppressed indivi-
duals [3]. In 2009, the UK Joint Committee for
Vaccination and Immunisation assessed the clinical,
epidemiological and economic evidence to inform
decisions about possible vaccination strategies against
varicella and concluded that a childhood varicella
programme would not be cost-effective [4]. However,
it was agreed that this recommendation would be
kept under review as new data on the epidemiology
of varicella and herpes zoster became available.
As varicella is not a notiﬁable disease in the UK,
multiple data sources are needed to assess its health-
care burden. Trends in hospitalisations for varicella
in England between 2004 and 2013, assessed using
inpatient Hospital Episode Statistics, were recently
published and showed that hospitalisation rates were
broadly stable [5]. Here, we report trends in the bur-
den of varicella seen in general practice, by age and
ethnicity.
The data source used was the Clinical Practice
Research Datalink (CPRD), a large database of anon-
ymised UK general practice records comprising a rep-
resentative sample of approximately 7% of the UK
population [6]. The study population comprised all
patients registered with CPRD practices that met
CPRD-deﬁned data quality standards (‘up to stand-
ard’ (UTS) data) between 1 January 2005 and 31
December 2014. The start of follow-up for each indi-
vidual was the latest of their registration date (if aged
46 months at registration), 6 months after their regis-
tration date (for patients aged >6 months at registra-
tion, to exclude historical episodes of varicella
recorded retrospectively when the patient joined the
practice), the practice UTS date and 1 January 2005
[7]. Individuals’ end of follow-up was the earliest of
the date they left the practice or died, the practice’s
last data collection date and 31 December 2014.
General practice consultations for varicella were iden-
tiﬁed using Read codes and consultation codes that
indicated a general practice contact, excluding consul-
tations from other settings (e.g. hospitalisations).
Covariates of interest included age, calendar year
and ethnicity. Age was initially categorised into <1,
1–3, 4–6, 7–10, 11–20 and >20 years, and then
categorised more ﬁnely to explore age differences by
ethnicity. Ethnicity was identiﬁed using the methods
of Mathur et al., with categorisation informed by
countries of origin where there may be later average
age at varicella, namely white, mixed, Caribbean,
South Asian, other Asian, African/other black and
other ethnicities [2,8].
In primary analyses, all varicella consultation-days
occurring in the 12 months after a ﬁrst-ever varicella
consultation were included; the rationale was that,
given the rarity of second episodes of varicella and
the expected short duration of uncomplicated vari-
cella, consultations occurring after the 12-month per-
iod in these analyses could be historical recording of
past varicella or miscoded non-varicella events. In
sensitivity analyses, consultations were (a) restricted
to those occurring in the 6 months after an initial vari-
cella consultation and (b) counted irrespective of vari-
cella history, including all consultation-days over
time. Poisson-distributed consultation rates with 95%
conﬁdence intervals (CIs) were calculated by age and
calendar year, using CPRD person-time denomina-
tors. Ethnic-speciﬁc consultation rate analyses were
restricted to 2006–2012, the years during which gen-
eral practitioners (GPs) were ﬁnancially incentivised
to record patients’ ethnicity [9].
Approval for the study was obtained from the
Independent Scientiﬁc Advisory Committee of the
Medicines and Healthcare Products Regulatory
Agency (ISAC number: 15_065) and from the Ethics
Committee of the London School of Hygiene &
Tropical Medicine (LSHTM reference: 12133).
There were 8 432 826 individuals recorded for at
least 1 day in CPRD between 1 January 2005 and
31 December 2014. Median follow-up time was 4·9
years (interquartile range 1·8–9·3 years). During the
study period, 151 716 individuals had a ﬁrst-ever vari-
cella event recorded. These individuals had 160 166
varicella consultations; 141 586 individuals (93·3%)
had a single varicella consultation and 10 130 had
one or more subsequent varicella consultation
recorded 1 day to 9·6 years later. In total, 62% of
those with multiple varicella consultations completed
all subsequent consultations within 30 days of the ini-
tial consultation, and 76% completed their consulta-
tions within 12 months. Only 2711 consultations
(1·7%) occurred more than 12 months after the
ﬁrst-ever varicella consultation and these were
excluded from the primary analysis.
The number of consultations peaked in 2007 at 20
603 and then fell over time to a low of 11 243 in 2014.
Age-speciﬁc varicella consultation rates for each year
of the study period are summarised in Fig. 1a.
Consultation rates declined over time across all age
groups, with decreases ranging from 6% (in 4–6
years old) to 54% (in 20+ years old) over the entire
study period. Consultations were common among
infants, peaking at 41·5/1000 person-years in 2007,
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but the most frequent consultations were among chil-
dren aged 1–3 years (61·2 consultations/1000 person-
years in 2007, 39·7/1000 person-years in 2014). Rates
fell successively with increasing age; in those aged 20
+ years, the rates were less than one varicella consult-
ation/1000 person-years throughout the study period.
In the two sets of sensitivity analyses, the number of
consultations and consultation rates were very similar
to those in the main analysis (data not shown), reﬂect-
ing the very large proportion of individuals who had
only a single varicella record.
Age-speciﬁc consultation rates for 2006–2012 for the
seven ethnic groups, and for those with no ethnicity
recorded, are shown inFig. 1b. Completeness of record-
ing of ethnicity varied from 61% (among those aged <1
year) to 34% (among those aged 80+ years). For those
aged <16 years, there was a slight shift to older ages
at consultation for several non-white ethnic groups,
with lower rates below the age of 3 years but higher
rates for older children. For example, children of
black African and Afro-Caribbean origin had median
ages at consultation of 4·2 and 4·5 years, respectively,
Fig. 1. Varicella consultation rates: (a) with 95% conﬁdence intervals (dotted lines) by age and year; (b) by age for each
ethnic group (for the years 2006–2012).
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compared with amedian age of 2·8 years for children of
white ethnicity. Among older children aged 11–15
years, black African children had nearly three times
the consultation rates for varicella compared with
those of white ethnicity (4·7/1000 person-years, 95%
CI 3·7–5·7 vs. 1·6/1000 person-years, 95% CI 1·5–1·7),
with similar higher rates among South Asian, other
Asian and Afro-Caribbean children. These four non-
white ethnic groups also had higher consulting rates
(with non-overlapping 95% CIs) compared with those
of white ethnicity at ages 16–20 years (2·3–4·2/1000
person-years vs. 1·0/1000 person-years), and at ages
21–30 and 31–40 years. Among those aged 41–50
years, rates were higher for individuals of other Asian
and South Asian ethnic origin. Those with missing
information on ethnic origin had similar consultation
rates to those of white ethnic origin in all age groups.
To explore further the potential impact of missing
data, we repeated analyses restricted to 2012 (the year
for which ethnicity was most completely recorded);
results were almost identical to those obtained for
2006–2012 (data not shown).
We postulated that the decrease in general practice
consultation rates over the study period could be due
in part to changes in health-seeking behaviour. For
example, patients with varicella may have presented
increasingly over time to Accident and Emergency
(A&E) departments directly rather than attending
their GP as a result of changes in GP service provi-
sion, as has been suggested for other acute illnesses
in the UK [10]. We therefore analysed the proportion
of ﬁrst varicella consultations over time that had a
record on the same day indicating an A&E
Department visit or a hospitalisation. We found no
evidence of an increasing trend in varicella consulta-
tions in secondary care: for those aged 416 years,
2·8% of all ﬁrst varicella consultations in both 2005
and 2014 had a hospital visit recorded (with a peak
of 3·2% in 2011). Similarly, for >16 years old, 2·2%
of all ﬁrst varicella consultations were in hospital or
at A&E departments in 2005 compared with 2·8% in
2014 (peaking at 2·9% in 2010).
Our ﬁnding that the highest healthcare burden of
varicella was among very young children is consistent
with studies from an earlier era that showed changes
in the age distribution of varicella cases presenting
to general practice, with an increasing proportion of
cases among those aged <5 years [11]. It is thought
that this change reﬂects increasing daycare attendance
over time by pre-school children in the UK. Although
country of birth data are not well recorded in CPRD,
our ethnicity-speciﬁc analyses are consistent with
reports that age at varicella acquisition may be
delayed in some tropical countries and that adults in
some non-white ethnic groups are at increased risk
of varicella [2]. However, overall consultation rates
for varicella in adulthood remained low in these
groups. Among children, the older age at varicella
acquisition for several ethnic groups may also be
due in part to being born outside the UK, but could
also result from different mixing patterns in early
childhood, for example, lower daycare attendance.
Our study included a very large study population
that is broadly representative of the UK population
and with data available over a long period. Some esti-
mates of rates stratiﬁed by both age and ethnicity were
based on small numbers, although non-overlapping
conﬁdence intervals for estimates suggested that dif-
ferences in rates were unlikely to be due to random
error. The ethnicity analyses were also limited by
missing data. We did not classify those with no
recorded ethnicity as being from a white ethnic
group, an approach adopted by some researchers on
the basis that, if the study population reﬂected the
UK population, at least 93% of these individuals
would be likely to be of white ethnicity [12].
However, the almost identical rates at every age for
those of white and of unstated ethnicity does suggest
that most of these individuals were indeed of white
ethnic origin. With the removal of the contractual
requirement to record patients’ ethnicity, the extent
of missing data in general practice data may increase
in future analyses, although the British Medical
Association has suggested that practices would want
to continue to record routinely patients’ ethnicity to
enable assessment of the needs of their practice popu-
lation [9].
Some other potential limitations need consider-
ation. The outcome of interest was clinically diag-
nosed varicella without virological conﬁrmation.
However, varicella has a very characteristic clinical
presentation and misdiagnosis by GPs is unlikely.
Inclusion of all consultations in the 12 months after
the ﬁrst varicella record may have included some non-
varicella consultations, for example, GP recording of
past varicella or contacts with varicella, and this
may have resulted in overestimates of consultation
rates. However, we obtained near-identical consult-
ation rates when we repeated analyses after truncation
of later consultations to 6 months, and then when all
varicella consultations were included with no restric-
tions. Conversely, removal of duplicate varicella
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consultations on the same day may have removed
some genuine re-consultations for varicella, resulting
in slight underestimation of rates; but given that vari-
cella is generally a mild disease, it is likely that many
of these excluded same-day consultations were dupli-
cate recording (e.g. separate records for requesting
tests, or referrals).
As severe varicella is uncommon in healthy children
and uncomplicated varicella requires no speciﬁc treat-
ment, many varicella cases do not present to general
practice. Our study was not designed to estimate inci-
dence of varicella, but rather to contribute to esti-
mates of the healthcare burden of varicella in
different settings to inform future cost-effectiveness
analyses of any UK varicella vaccination programme.
A decrease in varicella cases seen in general practice
over time could be due to decreasing incidence of vari-
cella in the community, a tendency for GPs to diag-
nose varicella less often when patients present with
possible varicella, or changes in healthcare utilisation.
The ﬁrst two of these possible explanations seem
unlikely. We did not ﬁnd that the marked decrease
in general practice consultations observed over the
study period was mirrored by corresponding increases
in the burden seen in other healthcare settings. Recent
separate analyses of hospitalisation data in England
have shown no notable increases in varicella hospita-
lisations over a similar time period [5]. However, we
were only able to assess A&E attendance for varicella
using general practice records, and it is likely that
these attendances are under-recorded by GPs. Until
very recently, Hospital Episode Statistics A&E data
recorded only a small proportion of diagnoses made
in A&E settings and so these data could not be used
to identify varicella visits. Improvements to recording
of varicella diagnoses in A&E data, and in other data
sources such as calls to the NHS 111 phoneline, will
enable future assessment of changes in health-seeking
behaviour data and more complete data on varicella
cases across healthcare settings. This will maximise
assessment of the overall healthcare burden attributed
to varicella and support decision-making about
whether to introduce varicella vaccination in the UK.
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